An extraordinary general meeting held February 28 at Bellamy’s Australia Limited to consider resolutions to remove four of the company’s directors resulted in major changes at the company.
Reckitt Benckiser Group plc (RB) has confirmed it is in ‘advanced negotiations’ to acquire all Mead Johnson Nutrition shares for $90 each in cash, valuing Mead Johnson’s entire share capital at approximately $16.7bn.
Mead Johnson Nutrition has signed an agreement with Swiss company Ewopharma, a distributor of pharmaceutical and nutritional products in Central Eastern Europe, to launch Nutramigen PURAMINO in Czechia and Slovakia.
FREE ONLINE: October 18, 9am Central European Time
Mead Johnson Nutrition has agreed to pay $12m (€10.9m) to settle a US Securities and Exchange Commission (SEC) investigation into the "promotional practices" of its Chinese business.
US infant formula giant Mead Johnson Nutrition has applied to patent a "nutritional composition" it claims can provide "novel benefits...not possible with current offerings."
Mead Johnson Nutrition cannot foresee "how or when" the US Securities and Exchange Commission (SEC) will conclude its investigation into the promotional practices of its Chinese infant formula business.
US infant formula giant Mead Johnson Nutrition has bolstered its presence in the lucrative Asian market with the opening of a Singaporean research and production site.
Mead Johnson Nutrition has revealed that the US Securities and Exchange Commission (SEC) is probing “certain expenditures” relating to the promotion of infant formula products by its business in China.
Mead Johnson Nutrition is standing by its 2013 full-year forecast, despite recently slashing its infant formula prices in China by up to 15% in the midst of a government anti-trust probe.
Nestlé USA and Mead Johnson Nutrition have dismissed calls to remove genetically-modified organisms (GMO) from their infant formula products in the US – citing the approved use of GMOs by several national and global regulatory bodies.
Mead Johnson Nutrition is facing court in the US over allegations that its Enfamil brand powdered baby formula was responsible for the death of one infant and two cases of serious illness.
